STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma

Clinical trial NCT06465485 · COMPLETED

Trial details

NCT number: NCT06465485
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Eosinophilic Asthma

Start date: 2024-02-28
Primary completion: 2026-05-13
Enrollment: 504

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.